1. Home/
  2. Compounds/
  3. decitabine:navitoclax (2:1 mol/mol)

decitabine:navitoclax (2:1 mol/mol)

Synonyms

SourcesNames Used
CTRPv2decitabine:navitoclax (2:1 mol/mol)
PharmacoGx decitabine:navitoclax (2:1 mol/mol)

FDA Approval Status

Not Approved
Dataset Select
Download Data as CSV

Top molecular features associated with response to decitabine:navitoclax (2:1 mol/mol)


Feature TypeStandardized
Nominal ANOVA
mRNA LPAR2 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA STXBP5L CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA ZBTB18 CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA NUMA1 CTRPv2 pan-cancer AAC 0.17 1e-07
mRNA LDOC1L CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA FBLL1 CTRPv2 pan-cancer AAC 0.21 1e-07
mRNA HMGB1 CTRPv2 pan-cancer AAC 0.18 1e-07
mRNA ZBTB39 CTRPv2 pan-cancer AAC 0.19 1e-07
mRNA RAB13 CTRPv2 pan-cancer AAC -0.19 1e-07
mRNA CEBPG CTRPv2 pan-cancer AAC 0.17 1e-07
Download CSV